Sfoglia per AUTORE
TROIA R
Collezione AOU Città della Salute di Torino

  

Items : 15

Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma. in HemaSphere / Hemasphere. 2022 Sep 30;6(10):e786. doi: 10.1097/HS9.0000000000000786. eCollection 2022 Oct.
2022
AOU Città della Salute di Torino

Sonneveld P; Zweegman S; Cavo M; Nasserinejad K; Broijl A; Troia R; Pour L; Croockewit S; Corradini P; Patriarca F; Wu K; Droogendijk J; Bos G; Hajek R; Teresa Petrucci M; Ypma P; Zojer N; Minnema MC; Boccadoro M;

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14.
2021
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Beksac M; van der Holt B; Aquino S; Ludwig H; Zweegman S; Zander T; Zamagni E; Wester R; Hajek R; Pantani L; Dozza L; Gay F; Cafro A; De Rosa L; Morelli A; Gregersen H; Gulbrandsen N; Cornelisse P; Troia R; Oliva S; van de Velden V; Wu K; Ypma PF; Bos G; Levin MD; Pour L; Driessen C; et alii...

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. in Blood cancer journal / Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.
2021
AOU Città della Salute di Torino

Oliva S; Bruinink DHO; Rihova L; D'Agostino M; Pantani L; Capra A; van der Holt B; Troia R; Petrucci MT; Villanova T; Vsianska P; Jugooa R; Brandt-Hagens C; Gilestro M; Offidani M; Ribolla R; Galli M; Hajek R; Gay F; Cavo M; Omedé P; van der Velden VHJ; Boccadoro M; Sonneveld P;

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. in Annals of hematology / Ann Hematol. 2021 Feb;100(2):437-443. doi: 10.1007/s00277-020-04384-w. Epub 2021 Jan 3.
2021
AOU Città della Salute di Torino

Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P;

2020
AOU Città della Salute di Torino

Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; et alii...

2019
AOU Città della Salute di Torino

Sonneveld P; Cavo M; Palumbo A; Rocci A; Liberati AM; Offidani M; Gamberi B; Troia R; Bernardini A; Conticello C; Larocca A; Grammatico S; Saraci E; Gilestro M; Muccio VE; Spada S; Omedé P; Gambella M; Boccadoro M; Oliva S; Gambella M; Omedé P; Spada S; Muccio VE; Gilestro M; Saraci E; Grammatico S; Larocca A; Conticello C; et alii...

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.
2018
AOU Città della Salute di Torino

Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M; Bringhen S; Mina R; Cafro AM; Liberati AM; Spada S; Belotti A; Gaidano G; Patriarca F; Troia R; Fanin R; De Paoli L; Rossi G; et alii...

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma. in Frontiers in immunology / Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018.
2018
AOU Città della Salute di Torino

Gay F; Boccadoro M; D'Agostino M; Troia R; Oliva S; Oliva S; Troia R; D'Agostino M; Boccadoro M; Gay F;

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma. in European journal of haematology / Eur J Haematol. 2017 Mar;98(3):289-295. doi: 10.1111/ejh.12834. Epub 2017 Jan 5.
2017
AOU Città della Salute di Torino

Offidani M; Corvatta L; Bringhen S; Gentili S; Troia R; Maracci L; Larocca A; Gay F; Leoni P; Boccadoro M;

Melphalan hydrochloride for the treatment of multiple myeloma. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2017 Aug;18(11):1127-1136. doi: 10.1080/14656566.2017.1349102. Epub 2017 J
2017
AOU Città della Salute di Torino

Esma F; Salvini M; Troia R; Boccadoro M; Larocca A; Pautasso C;

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis. in Leukemia / Leukemia. 2017 Aug;31(8):1727-1734. doi: 10.1038/leu.2016.381. Epub 2016 Dec 23.
2017
AOU Città della Salute di Torino

Nagler A; Patriarca F; Caravita T; Falcone AP; Malfitano A; Cafro AM; Liberati AM; Troia R; Omedé P; Offidani M; Carella AM; Salvini M; Ria R; Campbell P; Spada S; Evangelista A; Catalano L; Musto P; Conticello C; Montefusco V; Petrucci MT; Oliva S; Gay F; Spencer A; Hajek R; Palumbo A; Boccadoro M;

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2014 Sep;23(9):1193-209. doi: 10.1517/13543784.2014.920821. Epub 2014 Ju
2014
AOU Città della Salute di Torino

Bringhen S; Gay F; Donato F; Troia R; Mina R; Palumbo A;

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Aug;14(8):1127-44. doi: 10.1517/14712598.2014.908848. Epub 2014 Apr 21.
2014
AOU Città della Salute di Torino

Donato F; Gay F; Bringhen S; Troia R; Palumbo A;

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors. in Expert opinion on drug discovery / Expert Opin Drug Discov. 2014 Aug;9(8):931-43. doi: 10.1517/17460441.2014.923838. Epub 2014 May 30.
2014
AOU Città della Salute di Torino

Pautasso C; Troia R; Genuardi M; Palumbo A;

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1517-27. doi: 10.1517/17425255.2013.827169. Epub 2013
2013
AOU Città della Salute di Torino

Gay F; Mina R; Troia R; Bringhen S;